With an expanded agenda, World Biosimilar Congress USA 2017 will exceed expectations. Featuring two dedicated streams - one for the business and strategic end, and the other for the analytical and manufacturing challenges that still exist on the scientific end.
The new analytical stream will allow us to dive deeper into the science of Biosimilar development - and all of the challenges that come along with it as more companies start to expand their pipelines and seek FDA approval.
Best of all, it will be back in sunny San Diego - because we know half the fun of these events is what happens outside the hotel.
This event is still co-located with Americas Antibody Congress 2017, Cell Culture World Congress USA 2017, and the newly added World Immunotherapy Congress USA 2017 where researchers will be showcasing nearly 40 hours of new preclinical and clinical data.